1. A budget impact analysis of budesonide/formoterol in patients with mild asthma in Egypt. (3rd October 2019) Authors: Elsisi, Gihan Hamdy; Carapinha, João; Amin, Wagdy; Thabet, Ehab; Elafify, Safaa; Amin, Mohamad; Hatem, Ashraf Journal: Journal of medical economics Issue: Volume 22:Number 10(2019) Page Start: 1047 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A budget impact analysis of lenalidomide in multiple myeloma Egyptian patients. (2nd October 2020) Authors: Elsisi, Gihan Hamdy; Carapinha, João L.; Afify, Rania; Elmoty, Mohamed Abd; Khalaf, Mohamed Journal: Journal of medical economics Issue: Volume 23:Number 10(2020) Page Start: 1168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A budget impact analysis of lenalidomide in multiple myeloma Egyptian patients. (2nd October 2020) Authors: Elsisi, Gihan Hamdy; Carapinha, João L.; Afify, Rania; Elmoty, Mohamed Abd; Khalaf, Mohamed Journal: Journal of medical economics Issue: Volume 23:Number 10(2020) Page Start: 1168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A cost-effectiveness analysis of the use of safety-engineered syringes in reducing HBV, HCV, and HIV burden in Egypt. (1st February 2019) Authors: Mostafa, Aya; Elsisi, Gihan Hamdy Journal: Expert review of medical devices Issue: Volume 16:Number 2(2019) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Budget impact analysis for dapagliflozin in type 2 diabetes in Egypt. (2nd August 2020) Authors: Elsisi, Gihan Hamdy; Anwar, Mohammed Moustapha; Khattab, Mohamed; Elebrashy, Ibrahim; Wafa, Alaa; Elhadad, Hemat; Awad, Mohamad; Carapinha, João L. Journal: Journal of medical economics Issue: Volume 23:Number 8(2020) Page Start: 908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Budget impact analysis of subcutaneous trastuzumab compared to intravenous trastuzumab in Saudi HER2-positive breast cancer patients. (4th May 2021) Authors: Elsamany, Shereef; Elsisi, Gihan Hamdy; Hassanin, Fayza; Jafal, Mohamed Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 21:Number 3(2021) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cost-effectiveness of six months versus 1-year adjuvant trastuzumab in HER2 positive early breast cancer in Egypt. (2nd June 2020) Authors: Elsisi, Gihan Hamdy; Nada, Yousery; Rashad, Noha; Carapinha, João; Noor, Ahmad O.; Almasri, Diena M.; Zaidy, Mostafa Al; Foad, Ahmed; Khaled, Hussien Journal: Journal of medical economics Issue: Volume 23:Number 6(2020) Page Start: 575 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dapagliflozin cost-effectiveness analysis in heart failure patients in Egypt. (31st December 2022) Authors: Abdelhamid, Magdy; Elsisi, Gihan Hamdy; Seyam, Ahmed; Shafie, Ahmed; Kirollos, Mary; Emad, Sandy; Mansy, Shady; Sobhy, Mohamed Journal: Journal of medical economics Issue: Volume 25:Number 1(2022) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Projecting the potential cost-effectiveness of dapagliflozin for chronic kidney disease in Kuwait. (31st December 2023) Authors: Swidan, Ahmed; Elsisi, Gihan Hamdy; Ibrahim, Mohamed M.; Aljazzar, Mohammad; Tawfik Sallam, Hossameldin Journal: Journal of medical economics Issue: Volume 26:Number 1(2023) Page Start: 271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗